The incidence of the composite of all-cause mortality, non-fatal MI, and stroke was numerically higher in the high galectin-3 group than in the low galectin-3 group in all subgroups, although statistical significance was not found in patients with diabetes, a relatively preserved renal function, and non-users of statin. This evidence concerns the gene LGALS3 and diabetes mellitus.